Osmopharm
Osmopharm AG, commonly referred to as Osmopharm, is a leading player in the pharmaceutical industry, headquartered in Switzerland (CH). Founded in 2001, the company has established a strong presence in Europe and beyond, focusing on the development and manufacturing of innovative pharmaceutical products. Osmopharm specialises in osmotic drug delivery systems, which are designed to enhance the efficacy and bioavailability of medications. Their unique approach to drug formulation sets them apart in a competitive market, allowing for improved patient outcomes. With a commitment to quality and innovation, Osmopharm has achieved significant milestones, including partnerships with major healthcare providers and a growing portfolio of patented technologies. The company continues to solidify its market position through a dedication to research and development, making it a trusted name in the pharmaceutical sector.
DitchCarbon Score
How does Osmopharm's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Osmopharm's score of 6 is higher than 82% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Osmopharm's reported carbon emissions
Osmopharm, headquartered in Switzerland (CH), currently does not have available carbon emissions data for recent years. As a result, specific figures regarding their emissions in kg CO2e, including Scope 1, 2, or 3 emissions, are not provided. In the absence of concrete emissions data, it is important to note that Osmopharm has not outlined any specific reduction targets or commitments to the Science Based Targets initiative (SBTi) or other climate pledges. This lack of publicly available information suggests that the company may still be in the early stages of developing a comprehensive climate strategy. As the industry increasingly prioritises sustainability and carbon neutrality, Osmopharm's future commitments and initiatives will be crucial in aligning with global climate goals.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Osmopharm is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
